Drug Type Small molecule drug |
Synonyms- |
Action inhibitors |
Mechanism PI3K family inhibitors(Phosphatidylinositol 3-kinase family inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Autoimmune Diseases | Discovery | - | 02 May 2024 | |
| Autoimmune Diseases | Discovery | - | 02 May 2024 | |
| Dermatophilosis | Discovery | - | 02 May 2024 | |
| Dermatophilosis | Discovery | - | 02 May 2024 | |
| Glomerulonephritis | Discovery | - | 02 May 2024 | |
| Glomerulonephritis | Discovery | - | 02 May 2024 | |
| Keloid | Discovery | - | 02 May 2024 | |
| Keloid | Discovery | - | 02 May 2024 | |
| Neoplasms | Discovery | - | 02 May 2024 | |
| Neoplasms | Discovery | - | 02 May 2024 |





